Cargando…
A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice
BACKGROUND: Metabolites of arachidonic acid such as prostacyclin (PGI(2)) have been shown to participate in the pathogenesis of pulmonary fibrosis by inhibiting the expression of pro-inflammatory and pro-fibrotic mediators. In this investigation, we examined whether iloprost, a stable PGI(2 )analogu...
Autores principales: | Zhu, Yuanjue, Liu, Yong, Zhou, Weixun, Xiang, Ruolan, Jiang, Lei, Huang, Kewu, Xiao, Yu, Guo, Zijian, Gao, Jinming |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848635/ https://www.ncbi.nlm.nih.gov/pubmed/20302663 http://dx.doi.org/10.1186/1465-9921-11-34 |
Ejemplares similares
-
The Prostacyclin Analogue Iloprost Modulates CXCL10 in Systemic Sclerosis
por: Colasanti, Tania, et al.
Publicado: (2022) -
Iloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungs
por: Schermuly, Ralph T, et al.
Publicado: (2007) -
A multicenter, retrospective study of patients with pulmonary arterial hypertension transitioned from parenteral prostacyclin therapy to inhaled iloprost
por: Channick, Richard N., et al.
Publicado: (2013) -
Hyperbaric Oxygen Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Yuan, Yuan, et al.
Publicado: (2021) -
Protective Role of Andrographolide in Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Zhu, Tao, et al.
Publicado: (2013)